The Ashton at Anderson Investor Presentation Fourth Quarter and Full Year 2025 March 11, 2026 SNDA NYSE Listed Forward-Looking Statements Explanatory Note As further described in the Company's Current Report on Form 8-K filed with the SEC on March 11, 2026, the Company completed its previously announced acquisition of CNL Healthcare Properties, Inc. ("CHP") through a series of steps ending with a forward merger of CHP with and into a subsidiary of the Company (the "CHP merger" or "merger"), with such subsid ...

March 11, 2026 Cantor Global Technology & Industrial Growth Conference New York Hilton Midtown John Young, CFO Louis Gerhardy, VP Corporate Development AMBARELLA.COM COPYRIGHT AMBARELLA 2026 AMBARELLA.COM COPYRIGHT AMBARELLA 2026 Forward-Looking Statements This presentation contains forward-looking statements that are subject to many risks and uncertainties. All statements made in this presentation other than statements of historical facts are forward-looking statements, including, without limitation, state ...

Fourth Quarter and Full-Year 2025 Conference Call Presentation March 11, 2026 Broadwind | Investor Presentation 2023 1 This document contains "forward looking statements"—that is, statements related to future, not past, events—as defined in Section 21E of the Securities Exchange Act of 1934, as amended, that reflect our current expectations regarding our future growth, results of operations, financial condition, cash flows, performance, business prospects and opportunities, as well as assumptions made by, a ...

2026 RBC Global Financial Institutions Conference March 11, 2026 Welcome. The Huntington National Bank is Member FDIC. Huntington, Huntington Bank, and the Huntington Brandmark are service marks of Huntington Bancshares Incorporated. ©2026 Huntington Bancshares Incorporated. Abundant Green R: 126 G: 207 B: 28 Dark Teal R: 3 G: 79 B: 84 Pastel Teal R: 184 G: 239 B: 228 Pastel Magenta R: 248 G: 224 B: 229 White R: 255 G: 255 B: 255 Prosperous Sage R: 0 G: 45 B: 42 Primary Palette Off-White R: 245 G: 245 B: 24 ...

CADRE HOLDINGS FOURTH QUARTER 2025 March 11, 2025 FORWARD-LOOKING STATEMENTS Please note that in this presentation we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Compan ...

Crescent Biopharma (:) 2026 Conference March 11, 2026 08:40 AM ET Speaker0My name is Daina Graybosch. I'm a senior equity research analyst here at Leerink Partners. I'm excited this morning to welcome for the first time to the Leerink Global Healthcare Conference management from Crescent Biopharma or otherwise known as Crescent Biopharma, Ellie and Jonathan. In our 30 minutes we hope to talk through all three of their assets as well as a really interesting partnership that they did earlier this year. I thin ...

NeuroPace (NasdaqGM:NPCE) 2026 Conference March 11, 2026 08:40 AM ET Speaker1Okay. We can kick things off. Thanks, everybody, for joining. I'm Mike Kratky. I'm our Senior MedTech Analyst here at Leerink, and very pleased to be joined today by NeuroPace CEO Joel Becker, and CFO Patrick Williams, and in the crowd, Scott Schaper from Investor Relations as well. Gentlemen, thank you all for joining.Speaker2Thank you.Speaker0Thanks, Mike. Thanks for having us. Thanks to Leerink, looking forward to a great progra ...

Roivant Sciences (NasdaqGS:ROIV) 2026 Conference March 11, 2026 08:40 AM ET Speaker0Everybody.Speaker1Thank you, Claire.Speaker0My name is David Risinger. On behalf of Leerink Partners, just wanted to thank you for joining our conference. It's very much my pleasure to introduce Matt Gline, the CEO of Roivant. He's just putting a little sugar in his coffee.Speaker1Sorry.Speaker0We'll get started. Really appreciate you being here, and his team members, Richard and Kay are in the audience as well. I thought it ...

Twist Bioscience (NasdaqGS:TWST) 2026 Conference March 11, 2026 08:40 AM ET Speaker2Welcome to the final day of our Leerink Global Healthcare Conference. I'm Puneet Sahdev. I cover life science tools and diagnostics here, and it's my pleasure to be hosting the Twist Bioscience team, CEO Emily Leproust, and Adam Laponis, the CFO, joining us. Thanks for being here.Speaker1Thank you for this year.Speaker2Yeah, great. Lot to talk about, you know, on the NGS and bio protein expression services, the AI capabiliti ...

Jade Biosciences (NasdaqCM:JBIO) 2026 Conference March 11, 2026 08:40 AM ET Speaker2All right. Good morning, everyone. Thanks for joining us here on day three of the Leerink Partners Global Healthcare Conference. My name's Tom Smith. I'm one of the senior biotech analysts here at Leerink, and it's my pleasure to welcome our next company to the stage, Jade Biosciences, and really happy to be joined this morning by CEO Tom Frohlich and CSO and Head of R&D Andrew King. Gentlemen, thanks for joining us. Really ...